This archive contains the following articles listed by volume, issue and page number:

PEDIATRICS RELATED ARTICLES

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 279-290	Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease Author(s): Davis Courtaney, Ip Kendice, Banov Daniel, Zdoryk Oleksandr
Jul/Aug 2024 Pg. 268-269	Prescription: Pediatric/Geriatric Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 282-285	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jul/Aug 2024 Pg. 304-305	Calculations: Pediatric Dosing Consideration Author(s): Stockton Shelly J
Jul/Aug 2024 Pg. 309	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 312	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 446-448	Compounded "Monster Spray" for Nighttime Terrors: A Case Report Author(s): Riepl Mike
Nov/Dec 2023 Pg. 488	Calculations Author(s): Stockton Shelly J
Jan/Feb 2023 Pg. 72-77	Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 318	Calculations Author(s): Stockton Shelly J
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 258-262	Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Author(s): Odanaka Keita, Kojima Hiroki, Nakagawa Naoto
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 40	Calculations Author(s): Stockton Shelly J
Sep/Oct 2020 Pg. 408-412	Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Author(s): Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
Sep/Oct 2017 Pg. 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Mar/Apr 2017 Pg. 171-175	Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Jul/Aug 2016 Pg. 277-280	Case Report: Pediatric Scar Management After Open-heart Surgery Author(s): Phan Ha, Harger Beau, Estrada Nick
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Jan/Feb 2016 Pg. 6-10	Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Author(s): Choo Winnie
May/Jun 2015 Pg. 205-211	Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Author(s): Gonzalez Mark
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 427-431	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 364-368	Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Author(s): McElhiney Linda F
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 432-435	Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Author(s): Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
Jan/Feb 2013 Pg. 6-8	Pediatric Health Care: An Introduction Author(s): Williams LaVonn A
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Nov/Dec 2011 Pg. 446-448	A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients Author(s): Nolan Sara M, Burgess Christopher A
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 464-469	Diaper Rash Relief: Common Sense Remedies and Treatments Author(s): Wiliams Kacee D, Williams LaVonn
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Jul/Aug 2011 Pg. 316-319	Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Author(s): Bramwell Bethany
May/Jun 2011 Pg. 194-199	Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Mar/Apr 2011 Pg. 156	Acetylcysteine 1% or 10% Oral Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 518	Glutathione 25% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jan/Feb 2010 Pg. 21-25	Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2010 Pg. 6-8	When Traditional Medicine Fails Author(s): Bash Robert
Jan/Feb 2010 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Sep/Oct 2009 Pg. 431	Emanuel Butt Paste Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2009 Pg. 14-18	Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jan/Feb 2009 Pg. 63	Calculations Author(s): Stockton Shelly J
Jan/Feb 2009 Pg. 64	Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 65	Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 68	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 69	Diphenhydramine Hydrochloride 25-mg Gelatin Troches Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
May/Jun 2008 Pg. 261	Benzyl Benzoate Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 73	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007 Pg. 249	Methylphenidate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 116-120	Challenges of Compounding for Patients on the Ketogenic Diet Author(s): McElhiney Linda F
Mar/Apr 2007 Pg. 161	Ranitidine Hydrochloride 15-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Jan/Feb 2007 Pg. 17-19	Pediatric Oral Formulations: A Continual Challenge Author(s): Hurtado Josephine, Moffett Brady S
Jan/Feb 2007 Pg. 20-24	Sevelamer Suspension in Children with End-Stage Renal Disease Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 26-27	Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 27	Case Report: Treatment of Labial Adhesions in a Child Author(s): Fields Shannon W
Jan/Feb 2007 Pg. 68	Calculations Author(s): Stockton Shelly J
Jan/Feb 2007 Pg. 69	Caffeine Citrate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 70	Carbidopa 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 71	Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 75	Methyldopa 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 76	Metolazone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 77	Prednisone 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 78	Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 388	Nitrazepam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 390	Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 299	Adderall 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 302	Lisinopril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 303	Nifedipine 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 67	Propylthiouracil 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 410	Prescription: Pediatric Formulation Initiatives Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
Nov/Dec 2005 Pg. 433-434 View Sample	Wiping Out Diaper Rash Author(s): Fields Shannon W
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A
Jan/Feb 2005 Pg. 57	Calculations Author(s): Prince Shelly J
Jan/Feb 2005 Pg. 82-86	Stability of an Extemporaneously Compounded Propylthiouracil Suspension Author(s): Alexander Kenneth S, Mitra Pallabi
Nov/Dec 2004 Pg. 458-460	A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Author(s): McElhiney Linda F
Sep/Oct 2004 Pg. 329-335	Domperidone in Lactation: Use as a Galactagogue Author(s): Albright Lisa M
Sep/Oct 2004 Pg. 345-352	Head to Toe Solutions: A Quick Review of Current Therapies Author(s): Paoletti James E
Jul/Aug 2004 Pg. 244-249	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
May/Jun 2004 Pg. 184	Gag Tablet Lollipops Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2004 Pg. 214	Amiodarone HCl 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 215	Atenolol 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 218	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 134	Flucytosine 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 135	Griseofulvin 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 140	Stomatitis Mouthwash Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 141	Tacrolimus 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 142	Tiagabine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 474	Sulfasalazine 250-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2003 Pg. 485-489	Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Author(s): Haase Mark R, Khan Mansoor A, Bonilla Jeremiah
Sep/Oct 2003 Pg. 381	Thioridazine HCl 100-mg/mL Concentrated Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 376	Isoniazid 10-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 382	Ursodiol 150-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
Sep/Oct 2003 Pg. 394-398	Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Author(s): McElhiney Linda F
Jul/Aug 2003 Pg. 313-319	Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Author(s): Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Nov/Dec 2002 Pg. 419-421	Pediatric Dermatitis Author(s): Remmert Renee
Nov/Dec 2002 Pg. 423	Excerpts from and Reviews of Current Published Literature: Pediatric Medications Author(s): Foy Elizabeth, MacCara Mary E
Nov/Dec 2002 Pg. 424-425	Book Reviews: Compounding for Pediatric Patients Author(s): Ashworth Lisa D, Reed-Kane Dana
Nov/Dec 2002 Pg. 449	Caffeine and Sodium Benzoate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 451	Dimenhydrinate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 367	Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2001 Pg. 436-437	Topical Secretin for the Treatment of Autism Author(s): King Erin, Toney Steve
Jul/Aug 2001 Pg. 294-297	Basics of Compounding: Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 296	Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 296	Sugar-Free Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Spironolactone Oral Suspension 2-mg/mL Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Progesterone Oral Suspension 40-mg/mL Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 297	Xanthan Gum Oral Suspension Vehicle 0.3% Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 306	Pediatric Preoperative Cocktail Injection Author(s): Allen Loyd V Jr
May/Jun 2001 Pg. 198-201	The Basics of Compounding Emulsions, Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 120-123	The Basics of Compounding Emulsions, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2001 Pg. 13-16	Flavoring: Compounding a Treat Author(s): Kloesel Lawson G
Jan/Feb 2001 Pg. 18-19	Autism in Children Author(s): Cave Stephanie
Jan/Feb 2001 Pg. 21-22	Methylphenidate in the Treatment of Attention Deficit Disorders Author(s): Tenreiro Kim
Jan/Feb 2001 Pg. 23-25	A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature Author(s): Foy Elizabeth, MacCara Mary E
Jan/Feb 2001 Pg. 30-31	Compounding in History: Pediatric Considerations Author(s): Worthen Dennis B
Jan/Feb 2001 Pg. 38	Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 42	Cholestyramine 6.5% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 43	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 44	Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 45	Lorazepam 1-mg Chewable Gummy Gels Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 46	Metronidazole Benzoate 400-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 48	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 49	Niacinamide 4% Acne Gel Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 51	Promethazine HCl 50-mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 289-293	Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 305	Ondansetron HCl 8-mg/mL in PLO Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 164-169	Compounding Ear, Nose and Throat Preparations Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 171-174	Xylitol in the Prevention of Otitis Media Author(s): Glasnapp Andrew
May/Jun 2000 Pg. 175	Sildenafil 0.2% Otic Drops Author(s): Holland Robert T, Quisling Richard
May/Jun 2000 Pg. 208	Amphotericin B 100-mg Troches Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 214	Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 122-125	Basics of Compounding: Compounding Solutions Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 136	Sugar-Free Suspension Structured Vehicle, USP Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 461-465	The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Linguet Base (Soft Lozenge) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Sorbitol Based Hard Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 462	Sucrose Based Hard Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 463	Polyethylene Glycol (PEG) Troches (Soft Lozenges) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 463	Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 464	Chewable Lozenges Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 474	Methotrexate 2.5-mg/5-mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 274-276	Extemporaneous Formulations in Pediatric Patients Author(s): Nahata Milap C
Mar/Apr 1999 Pg. 148-155	Analysis of Extemporaneous Alprostadil Formulations Author(s): Sarver Jeffrey G, Peng Ning, Lerdkanchanaporn Supaporn, Oravecz-Wilson Katherine, Alexander Kenneth S, Erhardt Paul W
Jan/Feb 1999 Pg. 10	Oral Ulceration Mouthwash Author(s): Allen Loyd V Jr
Nov/Dec 1998 Pg. 412	Alternatives for the Lactose-Intolerant Patient Author(s): Glasnapp Andrew
Sep/Oct 1998 Pg. 368	Pediatric Central Parenteral Nutrition Solution Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 369	Pediatric Central Parenteral Nutrition Solution with Heparin Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 370	Pediatric Peripheral Parenteral Nutrition Solution Author(s): Allen Loyd V Jr
Jul/Aug 1998 Pg. 268-269	Malathion Topical Lotion: Therapy for Resistant Head Lice Author(s): Glasnapp Andrew, Nguyen Linh
Jul/Aug 1998 Pg. 318-321	Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Author(s): Inagaki Kazuhiro, Kambara Motoya, Mizuno Munemichi, Gill Mark A, Nishida Mikio
Mar/Apr 1998 Pg. 159	Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Author(s): Allen Loyd V Jr
Mar/Apr 1998 Pg. 160-161	Vehicles for Compounding Oral Liquids: Some Practical Considerations Author(s): Palmer Henry A
Jan/Feb 1998 Pg. 83-88	Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Nov/Dec 1997 Pg. 414	Ketoconazole 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 321	Baclofen 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 322	Captopril 0.75-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 323	Diltiazem HCl 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 278-279	Stability of Bethanechol Chloride Oral Liquid Dosage Forms Author(s): Gupta Vishnu D, Maswoswe J
May/Jun 1997 Pg. 174	Allopurinol 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 176	Dipyridamole 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 179	Labetalol HCl 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 180	Metoprolol Tartrate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 183	Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 184	Spironolactone 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 188	Verapamil HCl 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 195-199	The Formulation Development and Stability of Spironolactone Suspension Author(s): Alexander Kenneth S, Vangala Shyam Sundar KS, White Donald B, Dollimore David
May/Jun 1997 Pg. 200-205	The Formulation Development and Stability of Metronidazole Suspension Author(s): Alexander Kenneth S, Vangala Shyam Sundar KS, Dollimore David
May/Jun 1997 Pg. 202	Metronidazole 15-mg/mL Suspension Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 90-92	Flavors and Flavoring Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 93-99	Compounded Suppositories and Pharmaceutical Care Author(s): Duncan-Hewitt Wendy, Rains John
Mar/Apr 1997 Pg. 101	Acetazolamide 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 102	Azathioprine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 103	Flecainide Acetate 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 104	Methylcellulose 1% to 5% Solutions Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 105	Methylcellulose Oral-Liquid Vehicles Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 106	Pediatric Chewable Gummy Gel Base Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 106	Pediatric Chocolate Troche Base Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 107	Pediatric Chewable Gummy Gels Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 108	Pediatric Chocolate Troche Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 109	Nystatin Popsicles Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 110	Procainamide HCl 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 111	Syrup NF Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 112	Tetracaine 20-mg Lollipops Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 113	Tetracycline Compound Troche Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 114	Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 13	Omeprazole (Prilosec) in the Atypical Patient, Administration of Author(s): Kane Dana Lynn
Jan/Feb 1997 Pg. 29	HDDM Hard Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 30	HDDM Soft Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 30	HDDM Sugar Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen-Modified Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 60-63	Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David

GERIATRICS RELATED ARTICLES